Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer
作者： Daniel Ayude , Francisco Javier Rodríguez-Berrocal , José Ayude , Sonia Blanco-Prieto , Lorena Vázquez-Iglesias
关键词: Follow up studies 、 Stage ii 、 Risk stratification 、 Prognostic factor 、 Tumour stage 、 Surgical oncology 、 Internal medicine 、 Colorectal cancer 、 Oncology 、 Medicine 、 Adjuvant chemotherapy
摘要: Background Nowadays, evaluation of colorectal cancer prognosis and decision-making for treatment continues to be based primarily on TNM tumour stage. Administration adjuvant chemotherapy is especially challenging stage II patients that can have very different disease-related outcomes. Therefore, more reliable prognostic markers need developed improve the selection at high risk recurrence. Our purpose assess value preoperative serum CA 72.4 stratification CRC patients.
biomedcentral.com
springer.com
core.ac.uk
paperity.org参考文章(41)
U Kressner, B Glimelius, R Bergström, G Lindmark, Limited clinical significance of the serum tumour marker CA 72-4 in colorectal cancer Anticancer Research. ,vol. 16, pp. 895- 898 ,(1996)
S. Aloe, R. DAlessandro, A. Spila, P. Ferroni, S. Basili, R. Palmirotta, M. Carlini, F. Graziano, R. Mancini, S. Mariotti, M. Cosimelli, M. Roselli, F. Guadagni, Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancer International Journal of Biological Markers. ,vol. 18, pp. 21- 27 ,(2003) , 10.5301/JBM.2008.1151
John L. Marshall, Risk Assessment in Stage II Colorectal Cancer Oncology. ,vol. 24, pp. 9- 13 ,(2010)
P Stieber, A Fateh-Moghadam, C Cramer, C Reuter, D Nagel, W Reiter, H Pahl, Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma Anticancer Research. ,vol. 17, pp. 2903- 2906 ,(1997)
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
D. Kerr, R. Gray, P. Quirke, D. Watson, G. Yothers, I. C. Lavery, M. Lee, M. J. O’Connell, S. Shak, N. Wolmark, , A quantitative multigene RT-PCR assay for prediction of recurrence in stage II colon cancer: Selection of the genes in four large studies and results of the independent, prospectively designed QUASAR validation study Journal of Clinical Oncology. ,vol. 27, pp. 4000- 4000 ,(2009) , 10.1200/JCO.2009.27.15_SUPPL.4000
Leonard B. Saltz, Adjuvant Therapy for Colon Cancer Surgical Oncology Clinics of North America. ,vol. 19, pp. 819- 827 ,(2010) , 10.1016/J.SOC.2010.07.005
Kathleen Lang, Jonathan R Korn, David W Lee, Lisa M Lines, Craig C Earle, Joseph Menzin, Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis. BMC Cancer. ,vol. 9, pp. 227- 227 ,(2009) , 10.1186/1471-2407-9-227
Jeng Yi Wang, Reiping Tang, Jy Ming Chiang, Value of carcinoembryonic antigen in the management of colorectal cancer Diseases of The Colon & Rectum. ,vol. 37, pp. 272- 277 ,(1994) , 10.1007/BF02048166
Inti Zlobec, Parham Minoo, Daniel Baumhoer, Kristi Baker, Luigi Terracciano, Jeremy R. Jass, Alessandro Lugli, Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer. Cancer. ,vol. 112, pp. 495- 502 ,(2008) , 10.1002/CNCR.23208